Compare ACA & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ACA | FOLD |
|---|---|---|
| Founded | 2018 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 4.5B |
| IPO Year | 2018 | 2006 |
| Metric | ACA | FOLD |
|---|---|---|
| Price | $106.94 | $14.37 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 2 | 9 |
| Target Price | ★ $120.00 | $27.25 |
| AVG Volume (30 Days) | 307.5K | ★ 3.3M |
| Earning Date | 05-29-2026 | 05-12-2026 |
| Dividend Yield | ★ 0.18% | N/A |
| EPS Growth | ★ 121.99 | 50.00 |
| EPS | ★ 4.24 | N/A |
| Revenue | ★ $2,883,400,000.00 | N/A |
| Revenue This Year | $6.26 | $20.50 |
| Revenue Next Year | $5.39 | $18.59 |
| P/E Ratio | $26.02 | ★ N/A |
| Revenue Growth | ★ 12.20 | N/A |
| 52 Week Low | $68.11 | $5.66 |
| 52 Week High | $131.00 | $14.39 |
| Indicator | ACA | FOLD |
|---|---|---|
| Relative Strength Index (RSI) | 36.77 | 69.51 |
| Support Level | $104.85 | $14.21 |
| Resistance Level | $111.55 | N/A |
| Average True Range (ATR) | 5.43 | 0.02 |
| MACD | -1.48 | -0.02 |
| Stochastic Oscillator | 17.35 | 78.57 |
Arcosa Inc is a manufacturer and producer of infrastructure-related products and services. It operates in three segments: Construction Products, Engineered Structures, and Transportation Products. The Construction Products segment produces and sells construction aggregates and manufactures and sells trench shields and shoring products and services for infrastructure-related projects. The Transportation Products segment manufactures and sells products for the inland waterway and rail transportation industries. The Engineered Structures segment manufactures and sells products for energy-related businesses, including structural wind towers, telecommunication structures, steel utility structures for electricity transmission and distribution, and storage and distribution containers.
Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.